---
id: nvision-quantum-technologies
name: NVision Quantum Technologies
website: nvision-quantum.com
founded: 2016
area: quantum-enhanced metabolic MRI
substrate_family: D
substrate_tags:
  - D.2
technology_platform_ids:
  - nv-diamond-quantum-sensing
technology_platform_name: Quantum sensing and hyperpolarization
funding_stage: series-a
total_funding_usd_m: 50
public: false
business_model: device_consumables
buyer:
  - provider
  - pharma
  - academic_lab
customer:
  - provider
  - pharma
buyer_urgency: high
buyer_wtp: high
sales_cycle: long
regulatory_burden: heavy
tam_usd_m: 12000
new_capability: A quantum-based polarizer that hyperpolarizes sugars in under three minutes, boosting their MRI signal over 10,000x so standard MRI systems can image tumor metabolism in real time.
data_centrality: supporting-evidence
data_ownership:
  - generated-in-house
  - proprietary
moat:
  - IP
  - wet-lab
  - regulatory-trust
primary_value_chain_layer: hyperpolarization instrumentation for metabolic imaging
input:
  - metabolic tracers (pyruvate/sugars) and parahydrogen
transformation_type: measure
output:
  - real-time hyperpolarized metabolic MRI of tumor metabolism and treatment response
technology_readiness_level: 6
limiting_factor: Clinical validation and regulatory approval of hyperpolarized tracers and the polarizer for routine oncology imaging.
commercialisation_status: pilot_deployment
barrier_to_entry: very-high
barrier_to_entry_logic: A commercially deployable parahydrogen-induced polarization system producing clinical-grade hyperpolarized tracers in minutes, backed by deep IP and chemistry.
hardness: very-hard
hardness_reason: Producing sterile, clinical-grade hyperpolarized metabolic tracers reliably in under three minutes and getting them through regulatory approval is a multi-disciplinary quantum-chemistry and clinical challenge.
last_verified: "2026-07-06"
---

## One-liner

Quantum-based polarizer (Polaris) that hyperpolarizes metabolic tracers so standard MRI scanners can image tumor metabolism in real time.

## Problem

Tumor metabolism reveals whether a therapy is working long before tumor size changes, but standard MRI cannot see metabolic flux. Existing metabolic imaging is slow, expensive, or requires radioactive PET tracers.

## Workaround

PET imaging (radioactive, limited to certain tracers) and biopsy or size-based response assessment, which are slow, coarse, and cannot track metabolism dynamically in real time.

## Entry wedge

Deploying the Polaris polarizer at leading cancer research centers for oncological studies (Memorial Sloan Kettering preclinical use, a Cambridge quantum-MRI hub) ahead of clinical studies.

## Method

Parahydrogen-induced polarization (PHIP) hyperpolarizes sugars such as pyruvate in under three minutes, boosting their MRI signal over 10,000x. Injected hyperpolarized tracer lets a standard MRI scanner measure cell metabolism directly, showing metabolic shifts in tumors and early therapy response.

## Validated by

USD 30M Series A plus about USD 19.5M in German government funding (roughly USD 50M total). Polaris in preclinical use at Memorial Sloan Kettering. Quantum-enhanced MRI hub established at the University of Cambridge. Clinical studies planned as systems deploy through 2026.

## Competes with

Dissolution-DNP hyperpolarization systems (GE SigNa-style / former GE Healthcare research polarizers, NVIDIA-adjacent academic DNP) and PET metabolic imaging.

## Complements

MRI installed base at cancer centers, pharma oncology trials needing early response biomarkers, and radiology and metabolic-imaging research groups.

## Value chain position

**Downstream of:** parahydrogen chemistry, polarizer engineering, and tracer formulation.
**Upstream of:** oncology clinicians and pharma trials reading tumor metabolism on existing MRI scanners.

## Gaps

Not yet cleared for routine clinical use; deployments are preclinical/research with clinical studies pending. Funding combines a USD 30M round plus government grants. Founding year approximate.

## Notes

Ulm, Germany (TUM / Ulm lineage). IMPORTANT platform note: NVision uses parahydrogen-induced hyperpolarization (PHIP), not nitrogen-vacancy diamond quantum sensing. Linked to nv-diamond-quantum-sensing as the closest quantum-sensing primitive in the enum, but the mechanism is hyperpolarization chemistry, not NV centers. Flag the mismatch when reasoning about the primitive cluster.

## News signals
- 2025-12: NVision metabolic MRI technology advancing oncology research, with Polaris in use at Memorial Sloan Kettering. (source: https://www.businesswire.com/news/home/20251209400857/en/NVision-Metabolic-MRI-Technology-Advances-Oncology-Research)
